Acute Investment Advisory’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,592
Closed -$232K 19
2025
Q1
$232K Buy
+1,592
New +$231K 1.17% 16
2022
Q3
Sell
-32,388
Closed -$4.15M 37
2022
Q2
$4.15M Buy
32,388
+19,272
+147% +$2.53M 3.23% 13
2022
Q1
$1.8M Buy
+13,116
New +$1.74M 1.34% 21

Other funds holding XLV

Acute Investment Advisory's XLV Position: Q2 2025 in Review

Acute Investment Advisory sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q2 2025, closing a stake of 1,592 shares — an estimated $232K sold.

Acute Investment Advisory first reported a position in XLV in Q1 2022 and held it in 3 quarters. The position peaked at $4.15M in Q2 2022. 1,682 funds tracked by Wall St. Rank hold XLV as of Q2 2025.

  • Acute Investment Advisory reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q2 2025 after selling out during the quarter.
  • Acute Investment Advisory sold 1,592 State Street Health Care Select Sector SPDR ETF shares in Q2 2025, an estimated $232K.
  • Acute Investment Advisory first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2022 and held it in 3 quarters.
  • Acute Investment Advisory's State Street Health Care Select Sector SPDR ETF position peaked at $4.15M in Q2 2022.
  • 1,682 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2025.

Based on Acute Investment Advisory's 13F filing for Q2 2025, filed 22 Jul 2025.